U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
RUPLIZUMAB
562JQF15GN
Investigational
General
Names
7
Classification
7
Identifiers
8
Subunits
4
Related Substances
1
RUPLIZUMAB
562JQF15GN
Investigational
General
Approval Year
Unknown
139,594
Names
7
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
RUPLIZUMAB
Official Name
English
ruplizumab [INN]
Common Name
English
BG9588
Code
English
HU5C8
Code
English
HU-5C8
Code
English
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Classification
7
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Prevention of rejection of pancreatic islet cell transplants.
FDA ORPHAN DRUG
123499
Biological Agent
Pharmacologic Substance
[C1909]
Biological Agent
[C307]
Monoclonal Antibody
NCI_THESAURUS
C20401
Designated
ORPHAN DRUG
Designated
Treatment of immune thrombocytopenic purpura.
FDA ORPHAN DRUG
109897
Designated
ORPHAN DRUG
Designated
Prevention of rejection of solid organ transplants.
FDA ORPHAN DRUG
120098
Designated
ORPHAN DRUG
Designated
Prevention and treatment of Factor VIII/Factor IX inhibitors in patients with hemophilia A or B.
FDA ORPHAN DRUG
113798
Showing 1 to 5 of 7 entries
Previous
1
2
Next
Identifiers
8
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
8014
PRIMARY
NCI_THESAURUS
C152273
PRIMARY
ChEMBL
CHEMBL2108767
PRIMARY
DRUG BANK
DB06475
PRIMARY
USAN
KK-92
PRIMARY
Showing 1 to 5 of 8 entries
Previous
1
2
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
562JQF15GN
RUPLIZUMAB